By proceeding, you agree to our Terms of Use and Privacy Policy.
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines.
26-28 July 2022
With two prostate cancer-focused approvals in the last year, RLT is finally getting the attention it deserves from investors, biotech, and the wider oncology field. Though still the 3rd line of exotic therapy, the ever-growing pipeline of therapeutic
Event Ended
USA
Paid
Boston